Pathologic complete response rate after neoadjuvant chemoradiation in patients with locally advanced rectal cancer affects survival in patients with prolonged radiation-surgery interval. This is an ...
Although tumor budding has been previously studied in esophageal carcinomas, little is known about its prognostic utility in superficial esophageal adenocarcinoma. An indication of its potential ...
Tumor budding appears to predict poor clinical outcome in cutaneous squamous cell carcinoma (CSCC) less than 4 cm in size, according to a study that looked specifically at this variable in a large ...
Tumour budding is an adverse prognostic indicator in colorectal cancer (CRC). Marked overall peritumoural inflammation has been associated with favourable outcome and may lead to the presence of ...
Use of circulating tumor DNA (ctDNA) for early assessment of treatment response in patients with advanced colorectal cancer (aCRC): A real-world (RW) analysis. This is an ASCO Meeting Abstract from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results